Skip to search formSkip to main contentSkip to account menu

Revasc

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

desirudin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Efficacy Outcomes of Endovascular Versus Surgical Revascularization in Critical Limb Ischemia: Results From a Prospective Cohort Study
Data on efficacy outcomes of endovascular versus surgical revascularization in patients with critical limb ischemia (CLI) in… 
2017
2017
Technique of delayed endovascular hemostatic closure for large bore vascular access site: A case series.
2016
2016
European Heart Journal-Cardiovascular Imaging Multi-Center Multi-Device Hybrid Imaging Study of Coronary Artery Disease . Results from the EValuation of INtegrated Cardiac Imaging for the Detection…
Manuscript Number: EHJCI-D-16-00104R1 Full Title: Multi-Center Multi-Device Hybrid Imaging Study of Coronary Artery Disease… 
2012
2012
Rebuttal to: Inappropriate use of risk score models for operative mortality in nonsurgical treatments by Luc Noyez, MD, PhD
2011
2011
Erratum to “Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study…
2011
2011
Erratum to A case of myocardial infarction effectively treated by emergency coronary stenting soon after a Bentall-De Bono aortic surgery (Cardiovasc Revasc Med 2010;11(4):263)
2005
2005
Long-Term Benefits and Limitations of Combined Antianginal Drug Therapy in Elderly Patients with Symptomatic Chronic Coronary Artery Disease
Background: Chronic angina is a common and disabling disorder in the elderly. Combined antianginal drug treatment represents the… 
2002
2002
[Desirudin (Revasc) to prevent thromboembolic complications after hip or knee replacement surgery].
Since March 1999, desirudin (REVASC), a recombinant hirudin, has been used in Nancy to treat patients who undergo total hip or… 
1997
1997
Effect of a 15-Minute Infusion of DDAVP on the Pharmacokinetics and Pharmacodynamics of ™REVASC during a Four-Hour Intravenous Infusion in Healthy Male Volunteers
Summary Plasma pharmacokinetics, effect on coagulation parameters, and safety and tolerability of an intravenous infusion of… 
Review
1994
Review
1994
Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).
BACKGROUND As a result of their polypeptidic nature, hirudins could theoretically elicit an immunologic response in humans… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)